FTC v. Endo Pharms., Inc.: The D.C. District Court “Treads [the] Tenuous Line Between Patent and Antitrust Laws” to Reject the FTC’s Challenge of an Exclusive License That Allegedly Discouraged Competition

Partners Stephen Larson and Adam Powell authored “FTC v. Endo Pharms., Inc.: The D.C. District Court ‘Treads [the] Tenuous Line Between Patent and Antitrust Laws’ to Reject the FTC’s Challenge of an Exclusive License That Allegedly Discouraged Competition,” which was published in The AIPLA Antitrust News, a publication of the AIPLA Committee on Antitrust Law.

Read the full article here.